Nasdaq is proud to welcome H. Lundbeck A/S (Lundbeck), (OTC – Nasdaq Intl Designation: HLUYY) to the Nasdaq International Designation Program. Lundbeck is a Denmark company, currently listed on Nasdaq Copenhagen under the symbol LUN. Lundbeck researches, manufactures, and sells drugs for people living with psychiatric and neurological disorders. The company has a market cap of $14.5 Billion USD. The Nasdaq International Designation program is designed for non-U.S.-based companies that have Level 1 American Depository Receipts or Canadian companies that have shares that trade on the over-the-counter (OTC) market.
As a member of the program, Lundbeck can now leverage additional visibility in the U.S. investment community and resources for investor relations support.
Nasdaq International continues increase the visibility of all member companies and we look forward to helping Lundbeck increase the visibility of their ADRs with US investors.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.